JP2024153733A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024153733A5 JP2024153733A5 JP2024118341A JP2024118341A JP2024153733A5 JP 2024153733 A5 JP2024153733 A5 JP 2024153733A5 JP 2024118341 A JP2024118341 A JP 2024118341A JP 2024118341 A JP2024118341 A JP 2024118341A JP 2024153733 A5 JP2024153733 A5 JP 2024153733A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- seq
- antibody
- nucleic acid
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962885781P | 2019-08-12 | 2019-08-12 | |
| US62/885,781 | 2019-08-12 | ||
| US201962886292P | 2019-08-13 | 2019-08-13 | |
| US62/886,292 | 2019-08-13 | ||
| JP2022509038A JP7631309B2 (ja) | 2019-08-12 | 2020-08-12 | Ｆｒｉｚｚｌｅｄ受容体抗体およびその使用 |
| PCT/CA2020/051103 WO2021026652A1 (en) | 2019-08-12 | 2020-08-12 | Frizzled receptor antibodies and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509038A Division JP7631309B2 (ja) | 2019-08-12 | 2020-08-12 | Ｆｒｉｚｚｌｅｄ受容体抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024153733A JP2024153733A (ja) | 2024-10-29 |
| JP2024153733A5 true JP2024153733A5 (https=) | 2025-06-06 |
Family
ID=74570316
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509038A Active JP7631309B2 (ja) | 2019-08-12 | 2020-08-12 | Ｆｒｉｚｚｌｅｄ受容体抗体およびその使用 |
| JP2024118341A Pending JP2024153733A (ja) | 2019-08-12 | 2024-07-24 | Ｆｒｉｚｚｌｅｄ受容体抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509038A Active JP7631309B2 (ja) | 2019-08-12 | 2020-08-12 | Ｆｒｉｚｚｌｅｄ受容体抗体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220356256A1 (https=) |
| EP (1) | EP4013793A4 (https=) |
| JP (2) | JP7631309B2 (https=) |
| CN (2) | CN120647760A (https=) |
| AU (1) | AU2020328475A1 (https=) |
| CA (1) | CA3147689A1 (https=) |
| WO (1) | WO2021026652A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4012057A4 (en) | 2019-09-30 | 2022-10-12 | JFE Steel Corporation | METAL STRIP QUENCHING DEVICE, METAL STRIP QUENCHING METHOD AND METAL STRIP MANUFACTURING METHOD |
| WO2023250402A2 (en) * | 2022-06-22 | 2023-12-28 | Antlera Therapeutics Inc. | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103002911B (zh) * | 2008-09-26 | 2015-08-26 | 昂考梅德药品有限公司 | 卷曲蛋白结合药剂及其应用 |
| US20130295106A1 (en) * | 2008-09-26 | 2013-11-07 | Oncomed Pharmaceuticals, Inc. | Frizzled-Binding Agents And Uses Thereof |
| EP3033356B1 (en) * | 2013-08-14 | 2020-01-15 | Sachdev Sidhu | Antibodies against frizzled proteins and methods of use thereof |
| US10919968B2 (en) | 2016-01-29 | 2021-02-16 | Modmab Therapeutics Corporation | Frizzled5 protein-binding agents |
-
2020
- 2020-08-12 CN CN202411970641.XA patent/CN120647760A/zh active Pending
- 2020-08-12 AU AU2020328475A patent/AU2020328475A1/en active Pending
- 2020-08-12 CA CA3147689A patent/CA3147689A1/en active Pending
- 2020-08-12 WO PCT/CA2020/051103 patent/WO2021026652A1/en not_active Ceased
- 2020-08-12 CN CN202080071440.XA patent/CN114616246B/zh active Active
- 2020-08-12 EP EP20852290.4A patent/EP4013793A4/en active Pending
- 2020-08-12 US US17/634,891 patent/US20220356256A1/en active Pending
- 2020-08-12 JP JP2022509038A patent/JP7631309B2/ja active Active
-
2024
- 2024-07-24 JP JP2024118341A patent/JP2024153733A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024153733A5 (https=) | ||
| JP2020063262A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2026041845A5 (https=) | ||
| JP2020114210A5 (https=) | ||
| JP2021503455A5 (https=) | ||
| RU2018129962A (ru) | Композиции антител к ror1 и соответствующие способы | |
| JP2018524349A5 (https=) | ||
| JP2019513018A5 (https=) | ||
| ME02637B (me) | Antitela za receptor 3 faktora rasta epiderma (her3) | |
| JP2010518820A5 (https=) | ||
| RU2019143101A (ru) | Новое анти-с-мет антитело и его применение | |
| JPWO2020068752A5 (https=) | ||
| JPWO2020114480A5 (https=) | ||
| JP2021522347A5 (https=) | ||
| JP2021512604A5 (https=) | ||
| JP2024001073A5 (https=) | ||
| CN114829405B (zh) | 抗bcma/抗4-1bb双特异性抗体及其用途 | |
| JPWO2019210848A5 (https=) | ||
| JPWO2021129672A5 (https=) | ||
| AU2019306113B2 (en) | Anti-human PD-L1 antibodies and their uses | |
| JPWO2020076799A5 (https=) | ||
| JPWO2020028428A5 (https=) | ||
| JPWO2019152895A5 (https=) | ||
| JPWO2022159984A5 (https=) |